According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of ...

Tuberculosis remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant ...

Doctors say child-friendly versions of TB medications would help treat younger patients, but a new report highlights why they so difficult to obtain in Canada ...

New options make TB treatment faster, safer, and more accessible. A major breakthrough in tuberculosis treatment has emerged: ...

An international trial identified three new, all-oral drug regimens for drug-resistant tuberculosis, improving treatment ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

HealthDay News — In a clinical practice guideline issued by the American Thoracic Society and published in the January issue of the American Journal of Respiratory and Critical Care Medicine, updated ...

Treatment of rifampin-resistant, fluoroquinolone-resistant TB: For adolescents aged 14 and older and adults with rifampin-resistant pulmonary TB who are resistant or intolerant to fluoroquinolones, ...